News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NovaBay Pharmaceuticals, Inc. (NBY)' Neutrophase Is Focus Of Dr. John Crew's Presentation At Advanced Wound Care Symposium


4/24/2014 7:25:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic anti-microbial products, today announced that Dr. John R. Crew, Medical Director of the Advanced Wound Care Center at Seton Medical Center in Daly City, California, will present at the Spring Symposium on Advanced Wound Care. Dr. Crew will explain to the doctors attending the meeting that NovaBay’s NeutroPhase® Advanced Wound Cleanser offers a significant advance in the treatment of flesh-eating infections.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES